Literature DB >> 25481375

Effects of Chelidonium majus extracts and major alkaloids on hERG potassium channels and on dog cardiac action potential - a safety approach.

Péter Orvos1, László Virág2, László Tálosi3, Zsuzsanna Hajdú4, Dezső Csupor4, Nikoletta Jedlinszki4, Tamás Szél2, András Varró5, Judit Hohmann6.   

Abstract

Chelidonium majus or greater celandine is spread throughout the world, and it is a very common and frequent component of modern phytotherapy. Although C. majus contains alkaloids with remarkable physiological effect, moreover, safety pharmacology properties of this plant are not widely clarified, medications prepared from this plant are often used internally. In our study the inhibitory effects of C. majus herb extracts and alkaloids on hERG potassium current as well as on cardiac action potential were investigated. Our data show that hydroalcoholic extracts of greater celandine and its alkaloids, especially berberine, chelidonine and sanguinarine have a significant hERG potassium channel blocking effect. These extracts and alkaloids also prolong the cardiac action potential in dog ventricular muscle. Therefore these compounds may consequently delay cardiac repolarization, which may result in the prolongation of the QT interval and increase the risk of potentially fatal ventricular arrhythmias.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arrhythmia; Berberine (PubChem CID: 2353); Cardiac action potential; Chelerythrine (PubChem CID: 2703); Chelidonine (PubChem CID: 10147); Chelidonium majus; Coptisine (PubChem CID: 72322); Greater celandine; QT interval; Sanguinarine (PubChem CID: 5154); hERG

Mesh:

Substances:

Year:  2014        PMID: 25481375     DOI: 10.1016/j.fitote.2014.11.023

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  7 in total

1.  Evaluation of anti-inflammatory and analgesic activities of extracts from herb of Chelidonium majus L.

Authors:  Przemysław Łukasz Mikołajczak; Bogdan Kędzia; Marcin Ożarowski; Radosław Kujawski; Anna Bogacz; Joanna Bartkowiak-Wieczorek; Wojciech Białas; Agnieszka Gryszczyńska; Waldemar Buchwald; Michał Szulc; Natalia Wasiak; Małgorzata Górska-Paukszta; Justyna Baraniak; Bogusław Czerny; Agnieszka Seremak-Mrozikiewicz
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

Review 2.  The Role of Biologically Active Ingredients from Natural Drug Treatments for Arrhythmias in Different Mechanisms.

Authors:  Jie Li; Dan Hu; Xiaoli Song; Tao Han; Yonghong Gao; Yanwei Xing
Journal:  Biomed Res Int       Date:  2017-04-11       Impact factor: 3.411

Review 3.  Natural products modulating the hERG channel: heartaches and hope.

Authors:  Jadel M Kratz; Ulrike Grienke; Olaf Scheel; Stefan A Mann; Judith M Rollinger
Journal:  Nat Prod Rep       Date:  2017-08-02       Impact factor: 13.423

4.  Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats.

Authors:  Yuzhen Jia; Binger Xu; Jisen Xu
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

5.  Herbal fertility treatments used in North America from colonial times to 1900, and their potential for improving the success rate of assisted reproductive technology.

Authors:  Cheryl Lans; Lisa Taylor-Swanson; Rachel Westfall
Journal:  Reprod Biomed Soc Online       Date:  2018-04-12

6.  Berberine improves insulin resistance in adipocyte models by regulating the methylation of hypoxia-inducible factor-3α.

Authors:  Yuanli Wang; Wenwen Gong; Shaofang Lv; Hongmei Qu; Yanling He
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

7.  Comparison of Anticancer Activity and HPLC-DAD Determination of Selected Isoquinoline Alkaloids from Thalictrum foetidum, Berberis sp. and Chelidonium majus Extracts.

Authors:  Anna Petruczynik; Tomasz Tuzimski; Tomasz Plech; Justyna Misiurek; Karolina Szalast; Grażyna Szymczak
Journal:  Molecules       Date:  2019-09-20       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.